Group One Trading, L.P. Altimmune, Inc. Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

A detailed history of Group One Trading, L.P. transactions in Altimmune, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 122,798 shares of ALT stock, worth $1.07 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
122,798
Previous 276,003 55.51%
Holding current value
$1.07 Million
Previous $1.84 Million 58.96%
% of portfolio
0.03%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$5.5 - $8.1 $842,627 - $1.24 Million
-153,205 Reduced 55.51%
122,798 $753,000
Q2 2024

Aug 14, 2024
SELL
$5.91 - $10.23 $197,724 - $342,254
-33,456 Reduced 10.81%
276,003 $1.84 Million
Q1 2024

May 10, 2024
SELL
$8.22 - $13.81 $1.96 Million - $3.29 Million
-237,982 Reduced 43.47%
309,459 $3.15 Million
Q4 2023

Feb 14, 2024
BUY
$2.14 - $11.62 $814,892 - $4.42 Million
380,791 Added 228.5%
547,441 $6.16 Million
Q3 2023

Nov 09, 2023
BUY
$2.4 - $3.45 $135,453 - $194,714
56,439 Added 51.21%
166,650 $433,000
Q2 2023

Aug 09, 2023
SELL
$3.45 - $5.97 $30,774 - $53,252
-8,920 Reduced 7.49%
110,211 $389,000
Q1 2023

May 12, 2023
SELL
$4.19 - $16.83 $237,200 - $952,763
-56,611 Reduced 32.21%
119,131 $502,000
Q4 2022

Feb 09, 2023
BUY
$8.74 - $16.45 $1.2 Million - $2.26 Million
137,151 Added 355.4%
175,742 $2.89 Million
Q3 2022

Nov 09, 2022
SELL
$10.67 - $22.41 $1.61 Million - $3.37 Million
-150,483 Reduced 79.59%
38,591 $493,000
Q2 2022

Aug 11, 2022
BUY
$3.94 - $11.77 $550,291 - $1.64 Million
139,668 Added 282.69%
189,074 $2.21 Million
Q1 2022

May 12, 2022
BUY
$5.9 - $9.45 $9,451 - $15,138
1,602 Added 3.35%
49,406 $301,000
Q4 2021

Feb 11, 2022
SELL
$8.69 - $12.48 $189,450 - $272,076
-21,801 Reduced 31.32%
47,804 $438,000
Q3 2021

Nov 12, 2021
BUY
$8.43 - $16.81 $23,157 - $46,177
2,747 Added 4.11%
69,605 $787,000
Q2 2021

Aug 10, 2021
BUY
$9.85 - $16.46 $175,605 - $293,448
17,828 Added 36.36%
66,858 $659,000
Q1 2021

May 12, 2021
SELL
$12.71 - $24.31 $335,569 - $641,832
-26,402 Reduced 35.0%
49,030 $693,000
Q4 2020

Feb 10, 2021
BUY
$7.84 - $14.22 $76,079 - $137,990
9,704 Added 14.76%
75,432 $851,000
Q3 2020

Nov 12, 2020
BUY
$9.93 - $33.26 $652,679 - $2.19 Million
65,728 New
65,728 $868,000
Q1 2019

May 13, 2019
SELL
$2.54 - $4.54 $1,188 - $2,124
-468 Closed
0 $0
Q4 2018

Feb 06, 2019
BUY
$1.72 - $7.24 $804 - $3,388
468 New
468 $1,000

Others Institutions Holding ALT

# of Institutions
186
Shares Held
39.3M
Call Options Held
913K
Put Options Held
743K
View Full List

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $426M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email